Stallergenes and Shionogi Sign Exclusive Partnership Agreements for Immunotherapy Tablets in Japan
Stallergenes S.A. has announced today the signing of exclusive partnership agreements with Shionogi & Co., Ltd. for two sublingual allergen immunotherapy tablet products resulting from the Stalair program: Actair house dust mite tablets and Japanese cedar pollen tablets.
Read more on PR Newswire via Yahoo! Finance